1st Quarter - Report
PRIME THERAPEUTICS for PRIME THERAPEUTICS
Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Proposed rule Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program - retail pharmacy networks, preferred cost sharing, mail order fulfillment, non interference
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FAHRNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.